Login / Signup

Effect of Renal Impairment on the Pharmacokinetics and Pharmacodynamics of Verinurad, a Selective Uric Acid Reabsorption Inhibitor.

William B SmithJesse HallJolene K BergMichal KazimirAmy YamamotoSusan WalkerCaroline A LeeZancong ShenDavid M WilsonDongmei ZhouMichael GillenThomas C Marbury
Published in: Clinical drug investigation (2018)
NCT02219516.
Keyphrases
  • uric acid
  • metabolic syndrome